Tags

Type your tag names separated by a space and hit enter

Cardiovascular risk in women with polycystic ovary syndrome.
Minerva Endocrinol. 2007 Dec; 32(4):263-73.ME

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed.

Authors+Show Affiliations

Cho LW
Department of Medicine, University of Hull, Hull, UK. l.cho@hull.ac.uk
Atkin SL
No affiliation info available

MeSH

AtherosclerosisBiomarkersBody WeightCardiovascular DiseasesDiabetes Mellitus, Type 2ExerciseFemaleHumansHypoglycemic AgentsMetforminPioglitazonePolycystic Ovary SyndromeRisk FactorsRisk Reduction BehaviorRosiglitazoneThiazolidinedionesVasodilator AgentsWeight Loss

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18091663

Citation

Cho, L W., and S L. Atkin. "Cardiovascular Risk in Women With Polycystic Ovary Syndrome." Minerva Endocrinologica, vol. 32, no. 4, 2007, pp. 263-73.
Cho LW, Atkin SL. Cardiovascular risk in women with polycystic ovary syndrome. Minerva Endocrinol. 2007;32(4):263-73.
Cho, L. W., & Atkin, S. L. (2007). Cardiovascular risk in women with polycystic ovary syndrome. Minerva Endocrinologica, 32(4), 263-73.
Cho LW, Atkin SL. Cardiovascular Risk in Women With Polycystic Ovary Syndrome. Minerva Endocrinol. 2007;32(4):263-73. PubMed PMID: 18091663.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cardiovascular risk in women with polycystic ovary syndrome. AU - Cho,L W, AU - Atkin,S L, PY - 2007/12/20/pubmed PY - 2008/2/29/medline PY - 2007/12/20/entrez SP - 263 EP - 73 JF - Minerva endocrinologica JO - Minerva Endocrinol VL - 32 IS - 4 N2 - Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed. SN - 0391-1977 UR - https://www.unboundmedicine.com/medline/citation/18091663/Cardiovascular_risk_in_women_with_polycystic_ovary_syndrome_ DB - PRIME DP - Unbound Medicine ER -